Central Laboratories White Papers & Articles

  1. What Is A Forward Deployed Engineer, And Why Do Clinical Trials Need One? 10/13/2026

    See how this model can compress traditional software development from a year or more into months, including a real example of an agent built to automatically detect CTMS milestone errors and anomalies. 

  2. Combining Multiple Challenge Models Within A Single Individual 10/8/2026

    Pairing immune challenges in healthy volunteers tests whether pharmacology is consistent across cells, tissue, and systemic responses before patient trials.

  3. What Most Psychiatric Drug Development Programmes Learn Too Late 10/8/2026

    Clinical phase completion doesn’t end uncertainty. Six key questions on brain exposure, pharmacology, therapeutic window, and patient variability can reveal whether the molecule failed, or the mechanism.

  4. Redesigning Regulatory Medical Writing For The AI Era 10/6/2026

    Faster drafts aren't faster submissions. See how to apply AI across medical writing with the governance and human review regulators expect.

  5. Early-Phase Lab Data: Why It Breaks And How To Prevent Risk 10/1/2026

    Learn why lab data systems built quickly in early-phase trials tend to outlast their usefulness, quietly accumulating inconsistencies that surface only when scrutiny intensifies later in a study.

  6. Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us 9/22/2026

    Controlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.

  7. AI In Precision Medicine: Predictive Insight To Operational Confidence 9/21/2026

    AI-enabled precision medicine trials depend on strong data governance and security, enabling predictive operational intelligence while preserving human oversight and appropriate conventional analytics.

  8. 7 Silent Quality-Killers Of Clinical Trial Success 9/21/2026

    Investigate seven hidden risks that quietly erode trial quality over time. Learn the early warning signs and how to catch and fix them before they escalate.

  9. AI, Open Source, & the Future of Biostatistics 9/18/2026

    AI and open-source tools are changing statistical programming. Learn how to validate, govern, and apply them without sacrificing the accuracy and oversight clinical research demands.

  10. Digital Twins: From Protocol Design to Predictive Study Execution 9/14/2026

    A growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.